Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy
Xiaoying Sun, Quan-xiu Dong, Jie Zhu, et al.
Current Alzheimer Research (2019) Vol. 16, Iss. 8, pp. 710-722
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease
Xiaoying Sun, Lingjie Li, Quan-xiu Dong, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 170
Neuroprotective Natural Products for Alzheimer’s Disease
Xin Chen, Joshua Adam Drew, Wren Berney, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1309-1309
Open Access | Times Cited: 152
Resveratrol Derivatives as Potential Treatments for Alzheimer’s and Parkinson’s Disease
Bruno Dutra Arbo, Corinne André‐Miral, Raif Gregorio Nasre-Nasser, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 119
New Insights Into Drug Discovery Targeting Tau Protein
Yoshiyuki Soeda, Akihiko Takashima
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 105
The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer’s Disease
Camila Calfío, Andrea González, Sandeep Kumar Singh, et al.
Journal of Alzheimer s Disease (2020) Vol. 77, Iss. 1, pp. 33-51
Closed Access | Times Cited: 74
Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer’s disease
Hind Muteb Albadrani, Payal Chauhan, Sumel Ashique, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116376-116376
Open Access | Times Cited: 15
Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese Medicine
Jing Li, Qingyin Long, Huang Ding, et al.
Advanced Science (2024) Vol. 11, Iss. 16
Open Access | Times Cited: 12
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Olumayokun A. Olajide, Satyajit D. Sarker
Inflammopharmacology (2020) Vol. 28, Iss. 6, pp. 1439-1455
Open Access | Times Cited: 61
Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases
Ryuuta Fukutomi, Tomokazu Ohishi, Yu Koyama, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 415-415
Open Access | Times Cited: 53
Antiplatelet drugs: Potential therapeutic options for the management of neurodegenerative diseases
Samir Kumar Beura, Rishika Dhapola, Abhishek Panigrahi, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 1835-1877
Closed Access | Times Cited: 20
Resveratrol differentially affects MMP‐9 release from neurons and glia; implications for therapeutic efficacy
Matthew Amontree, Matthew N. Nelson, Lara Stefansson, et al.
Journal of Neurochemistry (2024)
Open Access | Times Cited: 6
Oxyresveratrol Improves Cognitive Impairments and Episodic-like Memory through Modulating Neuroinflammation and PI3K-Akt Signaling Pathway in LPS-Induced Mice
Guangling Yin, Chunxing Pan, Hong Liu, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1272-1272
Open Access | Times Cited: 6
Natural products and phytochemical nanoformulations targeting mitochondria in oncotherapy: an updated review on resveratrol
Milad Ashrafizadeh, Sara Javanmardi, Masoumeh Moradi-Ozarlou, et al.
Bioscience Reports (2020) Vol. 40, Iss. 4
Open Access | Times Cited: 49
The effects of caloric restriction and its mimetics in Alzheimer's disease through autophagy pathways
Yi Yang, Lihui Zhang
Food & Function (2020) Vol. 11, Iss. 2, pp. 1211-1224
Closed Access | Times Cited: 46
Signaling mechanisms underlying inhibition of neuroinflammation by resveratrol in neurodegenerative diseases
Juan Huang, Nanqu Huang, Shang‐Fu Xu, et al.
The Journal of Nutritional Biochemistry (2020) Vol. 88, pp. 108552-108552
Closed Access | Times Cited: 46
Oxidative Stress in Tauopathies: From Cause to Therapy
Fernando Benito Bartolomé, Eva Carro, Carolina Alquézar
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1421-1421
Open Access | Times Cited: 24
Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities
Wei-Biao Zang, Huiling Wei, Weiwei Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116070-116070
Closed Access | Times Cited: 13
Evolution of lipid nanoparticles as charioteers of Alzheimer's disease therapeutics
Brati Chakraborty, Gayatri Patel, Bandana Padhan, et al.
Applied Materials Today (2024) Vol. 41, pp. 102442-102442
Closed Access | Times Cited: 4
Resveratrol: A “miracle” drug in neuropsychiatry or a cognitive enhancer for mice only? A systematic review and meta-analysis
Fatemeh Khorshidi, Anne Poljak, Yue Liu, et al.
Ageing Research Reviews (2020) Vol. 65, pp. 101199-101199
Closed Access | Times Cited: 30
Redox signaling and Alzheimer’s disease: from pathomechanism insights to biomarker discovery and therapy strategy
Yuanyuan Chen, Minchang Wang, Yanni Wang, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 29
Benefits of dietary polyphenols in Alzheimer’s disease
Farida El Gaamouch, Fiona Chen, Lap Ho, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 16
Targeting Protein Aggregates with Natural Products: An Optional Strategy for Neurodegenerative Diseases
Lingzhi Xiang, Yanan Wang, Shenkui Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11275-11275
Open Access | Times Cited: 8
Resveratrol targeting tau proteins, amyloid‐beta aggregations, and their adverse effects: An updated review
Milad Ashrafizadeh, Ali Zarrabi, Masoud Najafi, et al.
Phytotherapy Research (2020) Vol. 34, Iss. 11, pp. 2867-2888
Closed Access | Times Cited: 19
Role of Tau protein in long COVID and potential therapeutic targets
Bharat Marwaha
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 6
Resveratrol isoforms and conjugates: A review from biosynthesis in plants to elimination from the human body
Bruno Vincenzo Fiod Riccio, Larissa Spósito, Gabriela Corrêa Carvalho, et al.
Archiv der Pharmazie (2020) Vol. 353, Iss. 12
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top